Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Guardian Life Insurance Co. of America

Guardian Life Insurance Co. of America grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,301 shares of the pharmacy operator’s stock after purchasing an additional 22 shares during the period. Guardian Life Insurance Co. of America’s holdings in Walgreens Boots Alliance were worth $274,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of WBA. Hudock Capital Group LLC increased its holdings in shares of Walgreens Boots Alliance by 0.4% during the 1st quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $108,000 after acquiring an additional 5 shares during the last quarter. Tarbox Group Inc. increased its holdings in shares of Walgreens Boots Alliance by 288.3% during the 1st quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock valued at $113,000 after acquiring an additional 1,006 shares during the last quarter. Webster Bank N. A. increased its holdings in shares of Walgreens Boots Alliance by 18.4% during the 1st quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock valued at $125,000 after acquiring an additional 235 shares during the last quarter. MCF Advisors LLC boosted its stake in Walgreens Boots Alliance by 68.2% during the 1st quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock valued at $160,000 after purchasing an additional 780 shares during the period. Finally, Founders Capital Management bought a new stake in Walgreens Boots Alliance during the 1st quarter valued at approximately $161,000. 60.16% of the stock is currently owned by institutional investors.

Several analysts recently weighed in on the company. Needham & Company LLC set a $94.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Monday, July 17th. Pivotal Research set a $85.00 price objective on Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Sunday, July 2nd. Guggenheim reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Goldman Sachs Group, Inc. (The) restated a “neutral” rating and set a $77.00 target price (down previously from $89.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, June 28th. Finally, Morgan Stanley restated an “overweight” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and fifteen have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $92.06.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 13.50% of the stock is currently owned by insiders.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 78.41 on Friday. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $89.69. The firm has a market cap of $83.91 billion, a P/E ratio of 19.80 and a beta of 1.26. The company has a 50 day moving average price of $81.36 and a 200-day moving average price of $81.86.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The firm had revenue of $30.12 billion for the quarter, compared to analysts’ expectations of $29.72 billion. During the same quarter in the previous year, the company earned $1.18 earnings per share. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. On average, analysts expect that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current fiscal year.

Walgreens Boots Alliance declared that its Board of Directors has initiated a stock repurchase plan on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to reacquire up to 5.9% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board of directors believes its shares are undervalued.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th were given a $0.40 dividend. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.04%. Walgreens Boots Alliance’s payout ratio is presently 40.30%.

TRADEMARK VIOLATION NOTICE: This report was first published by BBNS and is the sole property of of BBNS. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at https://baseballnewssource.com/markets/walgreens-boots-alliance-inc-wba-stake-lifted-by-guardian-life-insurance-co-of-america/1604886.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with our FREE daily email newsletter.

 


Latest News

American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22


Leave a Reply

 
© 2006-2017 BBNS.